A- A A+

Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative. 

Krawczyk N, Bandara S, Merritt S, Shah H, Duncan A, McEntee B, Schiff M, Ahmad NJ, Whaley S, Latimore A, Saloner B. 

Addict Sci Clin Pract. 2022 Jun 2;17(1):30. doi: 10.1186/s13722-022-00313-6. PMID: 35655293; PMCID: PMC9161649.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161649/

Treatment preference for opioid use disorder among people who are incarcerated. 

Kaplowitz E, Truong AQ, Berk J, Martin RA, Clarke JG, Wieck M, Rich J, Brinkley-Rubinstein L. 

J Subst Abuse Treat. 2022 Jun;137:108690. doi: 10.1016/j.jsat.2021.108690. Epub 2021 Dec 13. PMID: 34930575.

Abstract

https://pubmed.ncbi.nlm.nih.gov/34930575/

Forscherteam fordert mehr Substitution im Maßregelvollzug

Psychisch kranke oder suchtkranke Straftäter, die nach § 64 Strafgesetzbuch (StGB) im Maßregelvollzug (Entziehungsanstalt) untergebracht sind, werden kaum substituiert. Um die Situation zu verbessern, hat ein Team um Prof. Dr. Heino Stöver, Leiter des Instituts für Suchtforschung Frankfurt am Main (ISFF) an der Frankfurt University of Applied Sciences, Chancen und Barrieren der Substitutionstherapie im Maßregelvollzug analysiert. Der subletter erhielt die Studie vorab. (Ursula Katthöfer, Wissenschaftsjournalistin, Bonn, in: subLetter 3/2022, Juni 2022, 29.05.2022, Anmeldung für Fachkreise erforderlich)

https://www.subletter.de/content/forscherteam-fordert-mehr-substitution-im-massregelvollzug

NRW. Richtungsweisendes Modellprojekt zur Behandlung von Hepatitis C im Justizvollzug in Nordrhein-Westfalen vorgestellt 

Projekt in der JVA Bochum unterstützt Ziel der Vereinten Nationen, Hepatitis C weltweit bis 2030 zu eliminieren. (Staatskanzlei des Landes Nordrhein-Westfalen, 19.05.2022)

https://www.land.nrw/pressemitteilung/richtungsweisendes-modellprojekt-zur-behandlung-von-hepatitis-c-im-justizvollzug

Global Prison Trends 2022

Global Prison Trends 2022 is the eighth edition of Penal Reform International’s annual flagship report published with the Thailand Institute of Justice, identifying the key trends and challenges in prison systems worldwide.

Two years into the COVID-19 pandemic, despite repeated calls to reduce prison populations since the onset of the crisis, the global prison population has reached an all-time high. Global Prison Trends 2022 exposes that, rather than a decrease in prison numbers, many governments are instead increasing prison capacity, with a significant expansion in the global prison estate in the past year. (Penal Reform International, UK, 11.05.2022)

https://www.penalreform.org/global-prison-trends-2022/

Increased risk of death immediately after discharge from compulsory care for substance abuse

Anders Ledberg, Therese Reitan

Drug and Alcohol Dependence, Available online 10 May 2022, 109492, doi.org/10.1016/j.drugalcdep.2022.109492

https://www.sciencedirect.com/science/article/pii/S0376871622002290

USA. California Inmate Overdoses Plummet Under Drug Program

The nation's largest medication-assisted treatment program for addicted prison inmates has reduced a surge in drug overdose deaths and hospitalizations plaguing California’s prison system. (U.S. News, USA, 25.04.2022)

https://www.usnews.com/news/health-news/articles/2022-04-26/california-inmate-overdoses-plummet-under-drug-program

Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail

Evans, Elizabeth A. et al.

Journal of Substance Abuse Treatment, Volume 0, Issue 0, 108746 

https://www.journalofsubstanceabusetreatment.com/article/S0740-5472(22)00028-9/fulltext

EMCDDA. Prisons and drugs: health and social responses

Introduction

This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide. It provides an overview of what to consider when planning or delivering health and social responses to drug-related problems in prisons, and reviews the available interventions and their effectiveness. It also considers implications for policy and practice. (EMCDDA, Lissabon, April 2022)

https://www.emcdda.europa.eu/publications/mini-guides/prisons-and-drugs-health-and-social-responses_en

USA. We Know Visitors Aren’t the Ones Bringing Drugs Into Our Prison

The Tennessee private prison where I’ve been incarcerated since 2016 has long maintained that the supply of contraband drugs here is mainly brought in by visitors. But for most of the past two years, all visitors have been barred from entering the facility, yet the flow of drugs didn’t stop. It increased, and so did the frequency of overdoses. The only people coming in and out were staff.  (Filter, USA, 22.03.2022)

https://filtermag.org/prison-contraband-drugs

Der Prozess der Kriminalisierung und Inhaftierung drogenkonsumierender Menschen in Deutschland. Implikationen für eine gesundheitsbezogene Rehabilitation und Resozialisierung.

Heino Stöver, Daniel Deimel, Anna Dichtl 

RPsych Jahrgang 7 (2021) Heft 4, Seite 489 – 514, doi.org/10.5771/2365-1083-2021-4-489

Zusammenfassung 

Sowohl im Rahmen der Strafverfolgung, des Gerichtswesens, im Strafvollzug als auch im Übergang vom Strafvollzug in Freiheit, kommt es wiederkehrend zu Kriminalisierungsprozessen von Konsumierenden illegaler Drogen. Im Rahmen des vorliegenden Beitrages werden die Dynamiken der Kriminalisierung von Drogenkonsumierenden nachvollzogen und deren negativen Auswirkungen auf die gesundheitliche und psychosoziale Situation dieser Menschen abgebildet. Die hieraus resultierende gesundheitliche Chancenungleichheit verstärkt eine Chronifizierung der Problemlagen und steht einer gesundheitsbezogenen Rehabilitation und Resozialisierung im Wege. Eine Reform der Drogenpolitik, durch Entkriminalisierung der Konsumierenden und eine Neuregulierung des Drogenmarktes sowie eine starke Fokussierung auf wirksame suchttherapeutische und sozialtherapeutische Maßnahmen im Justizvollzug sind daher dringend indiziert, um dieser gesundheitsbezogenen Ungleichheit entgegen zu wirken und eine Rehabilitation und Resozialisierung von drogenkonsumierenden Strafgefangenen zu ermöglichen.

https://www.nomos-elibrary.de/10.5771/2365-1083-2021-4-489/der-prozess-der-kriminalisierung-und-inhaftierung-drogenkonsumierender-menschen-in-deutschland-implikationen-fuer-eine-gesundheitsbezogene-rehabilitation-und-resozialisierung-jahrgang-7-2021-heft-4?page=1

Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study.

Russell C, Nafeh F, Pang M, MacDonald SF, Derkzen D, Rehm J, Fischer B. 

BMC Public Health. 2022 Mar 4;22(1):436. doi: 10.1186/s12889-022-12685-0. PMID: 35246083.

https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-022-12685-0

Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study. 

Cheng A, Badolato R, Segoshi A, McDonald R, Malone M, Vasudevan K, Badiei B, Sugarman A, Macdonald R, Mangat J, Giftos J, Lee JD, Tofighi B. 

Addict Sci Clin Pract. 2022 Jan 29;17(1):4. doi: 10.1186/s13722-022-00288-4. PMID: 35093164; PMCID: PMC8800291.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800291/

Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails. 

Sufrin C, Kramer CT, Terplan M, Fiscella K, Olson S, Voegtline K, Latkin C. 

JAMA Netw Open. 2022 Jan 4;5(1):e2144369. doi: 10.1001/jamanetworkopen.2021.44369. PMID: 35050354; PMCID: PMC8777564.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777564/

USA. Offering buprenorphine medication to people with opioid use disorder in jail may reduce rearrest and reconviction

Massachusetts jails found that people with opioid use disorder who were incarcerated and received a medication approved to treat opioid use disorder, known as buprenorphine, were less likely to face rearrest and reconviction after release than those who did not receive the medication. After adjusting the data to account for baseline characteristics such as prior history with the criminal justice system, the study revealed a 32% reduction in rates of probation violations, reincarcerations, or court charges when the facility offered buprenorphine to people in jail compared to when it did not. The findings were published in Drug and Alcohol Dependence. (NIDA – National Institute on Drug Abuse, USA, 18.01.2022)

https://nida.nih.gov/news-events/news-releases/2022/01/offering-buprenorphine-medication-to-people-with-opioid-use-disorder-in-jail-may-reduce-rearrest-and-reconviction?utm

Krankenhaus des Maßregelvollzugs: Therapiebedürftige sollen besser erkannt werden

Dtsch Arztebl 2022; 119(4): A-109 / B-93

afp; Maybaum, Thorsten

Straftäter mit einer Suchtproblematik können per Gerichtsbeschluss in Entziehungsanstalten eingewiesen werden – das genaue Vorgehen in solchen Fällen soll nun reformiert werden. Die Behandlung in den Krankenhäusern des Maßregelvollzugs (KMV) solle sich „wieder stärker auf diejenigen Personen konzentrieren, die wirklich eine Therapie brauchen“, erklärte Bundesjustizminister Marco Buschmann (FDP) kürzlich.

https://www.aerzteblatt.de/archiv/222941/Krankenhaus-des-Massregelvollzugs-Therapiebeduerftige-sollen-besser-erkannt-werden

Tablettenschmuggel für den großen Bruder - Der Fall Claudia J. (Video)

Stell dir vor, dein Bruder braucht dringend deine Hilfe. Dafür müsstest du das Gesetz brechen. Wie weit würdest du gehen? 

Claudia Jaworski hat Betäubungsmittel ins Gefängnis geschmuggelt, für ihren großen Bruder. Er ist seit vielen Jahren heroinabhängig. Um mit der Sucht besser leben zu können, nimmt er Ersatzdrogen. 

Doch in der JVA Bernau bekommt er keine Substitutionstherapie. (Der Fall (ZDF/ARD), 11.01.2022, Video, 09:37)

https://www.youtube.com/watch?v=Cvn9ZbGoGyQ

Trends in Buprenorphine Use in US Jails and Prisons From 2016 to 2021. 

Thakrar AP, Alexander GC, Saloner B. 

JAMA Netw Open. 2021 Dec 1;4(12):e2138807. doi: 10.1001/jamanetworkopen.2021.38807. PMID: 34905010; PMCID: PMC8672225.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672225/

Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015-2018: a repeated cross-sectional analysis. 

Bodkin C, Bondy S, Regenstreif L, Kiefer L, Kouyoumdjian F. 

BMJ Open. 2021 Nov 18;11(11):e048944. doi: 10.1136/bmjopen-2021-048944. PMID: 34794988; PMCID: PMC8603292.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603292/

A qualitative study of diphenhydramine injection in Kyrgyz prisons and implications for harm reduction. 

Meyer JP, Culbert GJ, Azbel L, Bachireddy C, Kurmanalieva A, Rhodes T, Altice FL. 

Harm Reduct J. 2020 Oct 31;17(1):86. doi: 10.1186/s12954-020-00435-7. PMID: 33129341; PMCID: PMC7603760.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603760/

Fifteen years of heroin-assisted treatment in a Swiss prison-a retrospective cohort study. 

Liebrenz M, Gamma A, Buadze A, Schleifer R, Baggio S, Schwartz B, Schneeberger A, Uchtenhagen A. 

Harm Reduct J. 2020 Oct 13;17(1):67. doi: 10.1186/s12954-020-00412-0. PMID: 33046103; PMCID: PMC7552491.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552491/

UK. Lifesaving antidote to be given to drug users as they leave custody

West Midlands Police has begun offering people with Class A drug addictions a lifesaving overdose antidote as they are released from custody as part of our wider harm reduction strategy.

The scheme, which is funded by the Police and Crime Commissioner Simon Foster, will hand drug users a medicine called Naloxone, which can reverse the effects of an overdose. (west midlands police and crime commissioner, UK, 03.11.2021)

https://www.westmidlands-pcc.gov.uk/lifesaving-antidote-to-be-given-to-drug-users-as-they-leave-custody/

Baden-Württemberg. JUSTIZVOLLZUG. Expertenkommission übergibt Medizinkonzept für Justizvollzug

Die Expertenkommission zur medizinischen Versorgung im baden-württembergischen Justizvollzug hat Justizminister Guido Wolf ihren Abschlussbericht übergeben. Im Bericht sind 30 konkrete Empfehlungen zur Weiterentwicklung der medizinischen Versorgung der Gefangenen angeführt. (Staatsministerium Baden-Württemberg, 19.3.2021)

https://stm.baden-wuerttemberg.de/de/service/presse/pressemitteilung/pid/expertenkommission-uebergibt-medizinkonzept-fuer-justizvollzug/

USA/NY. Hochul signs bills to address growing overdose crisis, expand treatment into jails, prisons

Advocates press governor to take further steps that reduce harm amid record overdose rates. (Times Union, USA, 07.10.2021)

https://www.timesunion.com/news/article/Hochul-signs-bills-to-address-growing-overdose-16517317.php

Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail. 

Lee JD, Malone M, McDonald R, Cheng A, Vasudevan K, Tofighi B, Garment A, Porter B, Goldfeld KS, Matteo M, Mangat J, Katyal M, Giftos J, MacDonald R. 

JAMA Netw Open. 2021 Sep 1;4(9):e2123032. doi: 10.1001/jamanetworkopen.2021.23032. PMID: 34495340; PMCID: PMC8427378.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427378/

Fatal overdoses after release from prison in British Columbia: a retrospective data linkage study. 

Kinner SA, Gan W, Slaunwhite A. 

CMAJ Open. 2021 Sep 28;9(3):E907-E914. doi: 10.9778/cmajo.20200243. PMID: 34584005; PMCID: PMC8486467.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486467/

Evaluation of a national smoke-free prisons policy using medication dispensing: an interrupted time-series analysis

Tweed, Emily J et al.

The Lancet Public Health, Volume 0, Issue 0 

https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(21)00163-8/fulltext

The impact of the COVID-19 lockdown on drug service provision in European prisons. 

Montanari L, Teltzrow R, Vanmalderen S, Ranieri R, Martín Peláez JA, Vandam L, Mounteney J, Pirona A, Meroueh F, Giraudon I, Matias J, Skarupova K, Royuela L, Morel d'Arleux J. 

Int J Prison Health. 2021 Aug 21;ahead-of-print(ahead-of-print). doi: 10.1108/IJPH-11-2020-0089. PMID: 34410050.

https://www.emerald.com/insight/content/doi/10.1108/IJPH-11-2020-0089/full/html

USA. Judge Rules in Favor of New York Prisoner Suing for Methadone Access

A District Court judge has issued a preliminary injunction to ensure that a 35-year-old Watertown, New York, resident can continue accessing his medication for opioid use disorder (MOUD) while detained in Jefferson County Jail. It’s the first such ruling in the Second Circuit, the Court of Appeals that includes New York state. (Filter, USA, 13.09.2021)

https://filtermag.org/new-york-jail-methadone-lawsuit

Strategies to maximise study retention and limit attrition bias in a prospective cohort study of men reporting a history of injecting drug use released from prison: the prison and transition health study. 

Stewart, A.C., Cossar, R., Walker, S. et al.

BMC Med Res Methodol 21, 185 (2021). doi.org/10.1186/s12874-021-01380-0

https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-021-01380-0